Zweig Advisers’s Bausch Health BHC Stock Holding History

Zweig Advisers’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-37,000	Closed	-$6.6M	–	71
2015 Q3	$6.6M	Buy	+37,000	New	+$8.63M	1.14%	51

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Zweig Advisers's BHC Position: Q4 2015 in Review

Zweig Advisers sold out of Bausch Health (BHC) in Q4 2015, closing a stake of 37,000 shares — an estimated $6.6M sold.

Zweig Advisers first reported a position in BHC in Q3 2015 and held it in 1 quarter. The position peaked at $6.6M in Q3 2015. 451 funds tracked by Wall St. Rank hold BHC as of Q4 2015.

Zweig Advisers reported no remaining Bausch Health position as of Q4 2015 after selling out during the quarter.
Zweig Advisers sold 37,000 Bausch Health shares in Q4 2015, an estimated $6.6M.
Zweig Advisers first reported a position in Bausch Health in Q3 2015 and held it in 1 quarter.
Zweig Advisers's Bausch Health position peaked at $6.6M in Q3 2015.
451 funds tracked by Wall St. Rank held Bausch Health as of Q4 2015.

Based on Zweig Advisers's 13F filing for Q4 2015, filed 16 Feb 2016.